decemb
first
case
novel
coronaviru
infect
diagnos
wuhan
china
due
intern
travel
humantohuman
transmiss
viru
spread
rapidli
insid
outsid
china
current
effect
antivir
treatment
therefor
research
effort
focus
rapid
develop
vaccin
antivir
drug
pro
proteas
constitut
one
attract
antivir
drug
target
address
emerg
problem
synthes
combinatori
librari
fluorogen
substrat
glutamin
posit
use
determin
substrat
prefer
sarscov
proteas
use
natur
larg
panel
unnatur
amino
acid
result
work
provid
structur
framework
design
inhibitor
antivir
agent
diagnost
test
decemb
sever
respiratori
diseas
unknown
origin
emerg
wuhan
hubei
provinc
china
symptom
first
patient
flulik
includ
fever
cough
myalgia
tendenc
develop
potenti
fatal
dyspnea
acut
respiratori
distress
syndrom
genet
analysi
confirm
betacoronaviru
caus
agent
viru
initi
name
novel
coronaviru
shortli
thereaft
renam
march
regist
cumul
case
countri
coronaviru
diseas
death
current
approv
vaccin
treatment
effort
made
character
molecular
target
pivot
develop
anticoronavir
therapi
main
proteas
pro
also
known
pro
one
coronavir
nonstructur
protein
design
potenti
target
drug
develop
pro
cleav
viral
polyprotein
gener
twelv
nonstructur
protein
includ
rnadepend
rna
polymeras
rdrp
helicas
inhibit
pro
would
prevent
viru
replic
therefor
constitut
one
potenti
anticoronavir
strategi
due
close
phylogenet
relationship
sarscov
main
proteas
share
mani
structur
function
featur
perspect
design
synthesi
new
pro
inhibitor
key
featur
enzym
abil
cleav
peptid
bond
follow
gln
sarscov
pro
cleav
polyprotein
within
ser
ala
gli
sequenc
indic
cleavag
site
appear
conserv
pattern
proteas
abil
peptid
bond
hydrolysi
gln
residu
also
observ
main
proteas
coronavirus
unknown
human
enzym
observ
along
studi
pro
potenti
lead
new
broadspectrum
anticoronavir
inhibitor
minimum
side
effect
present
studi
appli
hycosul
hybrid
combinatori
substrat
librari
approach
determin
full
substrat
specif
profil
sarscov
pro
pro
proteas
use
natur
larg
number
unnatur
amino
acid
divers
chemic
structur
allow
indepth
character
residu
prefer
bind
pocket
within
activ
site
proteas
result
librari
screen
enabl
us
design
synthes
acclabel
substrat
improv
catalyt
effici
comparison
substrat
contain
natur
amino
acid
moreov
result
studi
clearli
indic
sarscov
pro
pro
proteas
exhibit
overlap
substrat
specif
knowledg
appli
design
chemic
compound
effect
therapi
determin
sarscov
pro
pro
substrat
prefer
natur
unnatur
amino
acid
figur
incorpor
glutamin
posit
avail
crystal
structur
sarscov
pro
reveal
glutamin
small
number
cleavag
site
histidin
residu
occupi
pocket
enzym
imidazol
locat
bottom
proteas
explain
less
stringent
specif
pocket
form
hydrophob
interact
residu
limit
leucin
pocket
sar
pro
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
well
defin
also
reflect
substrat
specif
profil
pocket
occupi
small
residu
due
crowd
caviti
form
bottom
top
wall
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
valid
result
librari
screen
design
synthes
acclabel
substrat
contain
prefer
amino
acid
posit
measur
rate
substrat
hydrolysi
relev
proteas
figur
data
clearli
demonstr
sarscov
pro
pro
exhibit
activ
toward
test
substrat
result
consist
hycosul
screen
data
prefer
substrat
acabutleleuglnacc
compos
best
amino
acid
posit
kinet
paramet
determin
two
best
substrat
acabutleleuglnacc
acthztleleuglnacc
one
contain
best
recogn
natur
amino
acid
acvallysleuglnacc
tabl
toward
pro
due
substrat
precipit
due
high
concentr
need
assay
kinet
paramet
toward
sarscov
pro
could
determin
analysi
kinet
paramet
reveal
three
substrat
differ
k
cat
valu
k
valu
compar
copyright
holder
preprint
peerreview
summari
establish
substrat
specif
profil
posit
sarscov
pro
pro
proteas
use
combinatori
approach
data
clearli
demonstr
two
enzym
display
similar
substrat
prefer
inform
provid
use
design
inhibitor
activitybas
probe
reagent
use
solidphas
peptid
synthesi
follow
rink
amid
ra
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
gene
clone
recombin
product
sarscov
pro
describ
elsewher
combinatori
librari
synthesi
synthesi
h
naccresin
acc
synthesi
carri
accord
mali
et
al
glass
reaction
vessel
eq
mmol
g
rink
resin
ad
stir
gentli
per
min
dcm
h
filter
wash
time
dmf
fmocgroup
deprotect
perform
use
piperidin
dmf
three
cycl
min
filter
wash
dmf
time
six
time
next
eq
fmocaccoh
mmol
g
preactiv
eq
hobt
monohydr
mmol
g
eq
dici
mmol
ml
dmf
slurri
ad
resin
reaction
shake
gentli
hour
room
temperatur
time
resin
wash
four
time
dmf
reaction
repeat
use
eq
reagent
order
improv
yield
acc
coupl
resin
hour
resin
wash
dmf
fmoc
protect
group
remov
use
piperidin
dmf
min
filter
wash
dmf
six
time
fmocgln
trt
oh
mmol
g
eq
hatu
mmol
g
eq
collidin
mmol
ml
dmf
activ
min
ad
filter
cannula
eq
mmol
h
naccresin
reaction
carri
h
next
resin
wash
four
time
dmf
reaction
perform
use
eq
reagent
four
dmf
wash
fmoc
protect
group
remov
use
piperidin
dmf
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
multichem
synthesi
apparatu
flexchem
scigen
sunnyval
ca
usa
well
reaction
apparatu
eq
dri
h
ngln
trt
accresin
mmol
mg
ad
stir
gentli
minut
dcm
wash
four
time
dmf
separ
eppendorf
tube
eq
mmol
preactiv
eq
hobt
mmol
mg
eq
dici
mmol
dmf
next
preactiv
amino
acid
ad
well
apparatu
contain
h
ngln
trt
accresin
follow
h
agit
room
temperatur
reaction
mixtur
filter
wash
dmf
time
ninhydrin
test
carri
order
confirm
acid
coupl
subsequ
fmoc
protect
group
remov
use
piperidin
dmf
min
posit
coupl
isokinet
mixtur
portion
prepar
fmocprotect
natur
amino
acid
omit
cystein
plu
norleucin
mimick
methionin
amino
acid
total
next
eq
isokinet
mixtur
eq
hobt
mmol
g
eq
dici
mmol
ml
dilut
dmf
preactiv
min
activ
isokinet
mixtur
ad
well
contain
eq
h
trt
accresin
h
gentl
agit
slurri
filter
wash
dmf
time
ninhydrin
test
carri
fmoc
protect
group
remov
use
piperidin
dmf
min
procedur
appli
remain
compound
isokinet
mixtur
ad
prepar
posit
manner
posit
last
step
synthesi
nterminu
acetyl
perform
prepar
mixtur
compound
eq
acoh
mmol
eq
hbtu
mmol
g
eq
dipea
mmol
ml
ml
dmf
ad
falcon
tube
gentl
stir
min
mixtur
ad
well
reaction
apparatu
contain
h
trt
accresin
follow
gentl
agit
min
next
resin
wash
six
time
dmf
three
time
dcm
three
time
meoh
dri
p
sublibrari
perform
manner
describ
sublibrari
synthes
coupl
fix
aminoacid
residu
isokinet
mixtur
coupl
posit
isokinet
mixtur
coupl
hybrid
combinatori
substrat
librari
screen
perform
use
spectrofluoromet
molecular
devic
spectramax
gemini
xp
plate
corn
assay
condit
follow
substrat
enzym
incub
min
assay
buffer
mm
tri
mm
nacl
mm
edta
mm
dtt
ph
final
substrat
concentr
final
enzym
concentr
sarscov
pro
respect
releas
acc
measur
min
ex
nm
em
nm
linear
part
progress
curv
use
determin
substrat
hydrolysi
rate
substrat
specif
profil
establish
set
highest
valu
rel
fluoresc
unit
per
second
rfu
posit
other
adjust
accordingli
acclabel
substrat
synthes
solid
support
accord
solid
phase
peptid
synthesi
method
describ
elsewher
brief
fmocaccoh
eq
attach
rinkamid
resin
use
hobt
eq
dici
eq
dmf
coupl
reagent
fmoc
protect
group
remov
use
piperidin
dmf
three
cycl
min
fmocgln
trt
oh
eq
coupl
h
naccresin
use
hatu
eq
eq
dmf
fmoc
group
remov
eq
amino
acid
attach
hobt
dici
eq
dmf
amino
acid
posit
coupl
manner
free
nterminu
acetyl
use
hbtu
acoh
dipea
dmf
eq
reagent
resin
wash
five
time
dmf
three
time
dcm
three
time
meoh
dri
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
substrat
screen
carri
manner
librari
assay
substrat
concentr
sarscov
pro
pro
substrat
hydrolysi
measur
min
use
follow
wavelength
